Mayne Pharma Group's total assets for Q4 2024 were AU$1.14B, a decrease of -0.91% from the previous quarter. AU:MYX total liabilities were AU$688.99M for the fiscal quarter, a 13.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.